38 studies found for:    " March 05, 2008":" April 04, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Reactogenicity and Immunogenicity of Vaginal CNgp140
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Biological: HIV glycoprotein CN54gp140 (vaccine);   Biological: Carbopol 974
2 Completed Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Standard continuous antiretroviral therapy;   Drug: CD-4 guided therapy interruption;   Drug: Viral load driven treatment interruption
3 Completed Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Conditions: HIV Infections;   HIV Positive;   Pregnant Women
Intervention:
4 Completed Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss
Conditions: HIV Infections;   Unintended Weight Loss;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
5 Completed
Has Results
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
Conditions: HIV -1 Infection;   HIV Infections
Interventions: Drug: PRO 140 (humanized monoclonal antibody to CCR5);   Drug: Placebo Comparator
6 Completed HIV Prevention With the Mentally Ill
Condition: HIV Infections
Interventions: Behavioral: Skills Building with Motivational Interviewing;   Behavioral: Skills Building
7 Completed Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir and Lopinavir/ritonavir;   Drug: Raltegravir, emtricitabine, tenofovir
8 Completed Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Conditions: Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting;   HIV Infections
Interventions: Drug: Dronabinol;   Drug: Placebo
9 Completed Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples
Conditions: HIV Infections;   Sexually Transmitted Disease
Interventions: Behavioral: Eban HIV/STD Risk Reduction Intervention;   Behavioral: Eban Health Promotion Intervention
10 Completed Effectiveness of an Abstinence-Only HIV/Sexually Transmitted Disease Risk-Reduction Intervention for Young African-American Adolescents
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Abstinence-only HIV/STD risk-reduction intervention;   Behavioral: Safer-sex-only HIV/STD risk-reduction intervention;   Behavioral: Long comprehensive HIV/STD risk-reduction intervention;   Behavioral: Short comprehensive HIV/STD risk-reduction intervention;   Behavioral: Health promotion control intervention
11 Completed HORIZONS HIV Intervention
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: HORIZONS HIV Intervention;   Behavioral: enhanced standard-of-care
12 Completed
Has Results
Raltegravir Therapy for Women With HIV and Fat Accumulation
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: raltegravir
13 Completed An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Condition: HIV Infections
Intervention: Drug: Emtricitabine
14 Unknown  Effectiveness of Interactive Virtual Environment Games in Reducing Risky Sexual Behavior Among Men Who Have Sex With Men (The SOLVE-IT Study)
Condition: HIV Infections
Intervention: Behavioral: Socially Optimized Learning in a Virtual Environment (SOLVE)-IT
15 Unknown  Impact of Antiretroviral Therapy on Cardiac Biomarkers
Condition: HIV Infections
Intervention:
16 Completed Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
17 Completed
Has Results
HIV Screening in the Emergency Department Setting
Condition: HIV Infections
Interventions: Other: Targeted Screening;   Other: Routine Screening
18 Completed Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
19 Completed Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Abacavir
20 Completed Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)
Condition: HIV Infections
Interventions: Behavioral: Cognitive behavioral coping effectiveness training;   Behavioral: Standard care;   Behavioral: Single group workshop on coping effectiveness training

Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results
Indicates status has not been verified in more than two years